The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of...
TORONTO, July 24, 2025 /CNW/ - Global X Investments Canada Inc. ("Global X") is pleased to announce the distribution amounts per security (the "Distributions") for...
Dr. Adelola Ashaye has launched Metabolic Wellness & Healthy Weight Program at InTouch Primary Care, offering a personalized, medically guided approach to sustainable weight loss...
TRAIL Series features three ultra-compact DC-only portable power stations, including the 200, 300 and Plus 300
SEATTLE, July 24, 2025 /CNW/ -- EcoFlow, a leading provider...
TRAIL Series features three ultra-compact DC-only portable power stations, including the 200, 300 and Plus 300
SEATTLE, July 24, 2025 /PRNewswire/ -- EcoFlow, a leading provider...
2024's drill program was highly successful at converting Inferred resources, upgrading and expanding Indicated resources – meeting the key objectives and providing a foundation...
Paramus, NJ, July 23, 2025 (GLOBE NEWSWIRE) -- For many women, large breasts are not just a cosmetic concern, they’re a medical one. Chronic back, neck, and shoulder pain, rashes under the breasts, painful grooves from bra straps, posture problems, and even emotional distress are just some of the symptoms that can come with disproportionately large breasts.
The new suite of ETFs seeks to deliver true market capitalization exposure across five key sectors, addressing rising market concentration trends
NEW YORK, July 23, 2025...
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, August 5, 2025 to report its second quarter 2025 financial results and provide a corporate update.
CRANBURY, N.J., July 22, 2025 /PRNewswire/ -- NewBeauty , the definitive authority on all things beauty, has announced the release of The State of Aesthetics: By the...
WEXFORD, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, is pleased to announce the extinguishment of its convertible note with YA II PN, Ltd (“Yorkville”).
The American Academy of Orthopaedic Surgeons share expert tips to help players stay safe on the field
ROSEMONT, Ill., July 21, 2025 /PRNewswire/ -- Baseball...
Grand prize winners each take home $25,000 in prizes
CHANHASSEN, Minn., July 21, 2025 /PRNewswire/ -- Life Time (NYSE: LTH), the nation's premier healthy lifestyle...